Financials in USD. Standardized financial statements.
A compact view of how BlackRock Health Sciences Trust II turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue? | $24.07M | $8.19M | -$25.97M | $59.66M | $5.24M | $0 |
| Revenue Growth? | +193.8% | +131.5% | -143.5% | +1038.2% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | -$8.46M | $0 | $0 | $0 | $0 |
| Gross Profit? | $24.07M | $28.87M | -$25.97M | $6.40M | $5.24M | $0 |
| Gross Margin? | +100.0% | +352.4% | +100.0% | +10.7% | +100.0% | 0.0% |
| Operating Expenses? | $617,092 | $393,597 | -$25.97M | $6.35M | $5.17M | $0 |
| Operating Income? | $927,176 | $8.46M | $1.54M | $53,937 | $68,856 | $0 |
| EBITDA? | $23.50M | $20.02M | -$26.47M | $59.12M | $0 | $0 |
| Income Before Tax | $23.45M | $20.02M | -$26.47M | $59.12M | $79.56M | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | $23.45M | $20.02M | -$26.47M | $59.12M | $79.56M | $0 |
| EPS? | $1.77 | $1.44 | $-2.10 | $-2.55 | $11.63 | $1.45 |
| Diluted EPS? | $1.77 | $1.44 | $-2.10 | $-2.55 | $11.63 | $1.45 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality